JAC Advance Access originally published online on March 18, 2008
Journal of Antimicrobial Chemotherapy 2008 61(6):1389-1390; doi:10.1093/jac/dkn116
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Research letters |
Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium
1 Laboratory of Bacteriology, Hellenic Pasteur Institute, Athens, Greece 2 Division of Foodborne, Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA 3 Department of Microbiology, Medical School, University of Athens, Greece
* Corresponding author. Tel: +30-210-6478810; Fax: +30-210-6425038; E-mail: miriagou@pasteur.gr
Keywords: β-lactamase , cephalosporin , resistance
| The first 10% of the full text of this article appears below. |
Sir,
Resistance to extended-spectrum cephalosporins has emerged among non-typhoid salmonellae (NTS) worldwide due to acquisition of plasmid-mediated β-lactamases including CMY-2.1 The isolation frequency of CMY-2-producing NTS in the USA has gradually increased since 1996 reflecting the widespread transmission of CMY-2-positive NTS among food animal reservoirs. The blaCMY-2 gene has been disseminated by plasmids to various Salmonella serotypes including Typhimurium.2–4 We report here on a human isolate of Salmonella serotype Typhimurium harbouring a CMY-2-encoding plasmid as well as a chromosomally located copy of blaCMY-2.
Salmonella serovar Typhimurium AM19083 was submitted to the National Antimicrobial Resistance Monitoring System in 2003 from Massachusetts. Antimicrobial
| Funding |
|---|
| Transparency declarations |
|---|